Table 4.
NAME | SIZE | NOM p-val | FDR q-val | FWER p-val |
---|---|---|---|---|
KEGG_MAPK_SIGNALING_PATHWAY |
43 |
0 |
0 |
0 |
KEGG_LEISHMANIA_INFECTION |
20 |
0 |
0 |
0 |
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION |
35 |
0 |
0.007717 |
0.013 |
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS |
19 |
0.001976 |
0.006687 |
0.015 |
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY |
19 |
0.00211 |
0.016915 |
0.045 |
KEGG_FOCAL_ADHESION |
30 |
0.007619 |
0.025984 |
0.084 |
KEGG_COMPLEMENT_AND_COAGULATION_CASCADES |
16 |
0.015968 |
0.023016 |
0.087 |
KEGG_ECM_RECEPTOR_INTERACTION |
15 |
0.002053 |
0.022288 |
0.096 |
KEGG_CHEMOKINE_SIGNALING_PATHWAY |
32 |
0.008403 |
0.020502 |
0.1 |
KEGG_APOPTOSIS |
20 |
0.008584 |
0.018452 |
0.1 |
KEGG_VIRAL_MYOCARDITIS |
17 |
0.005906 |
0.017723 |
0.105 |
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY |
27 |
0.028902 |
0.037213 |
0.228 |
KEGG_GNRH_SIGNALING_PATHWAY |
19 |
0.044444 |
0.113272 |
0.563 |
KEGG_CELL_ADHESION_MOLECULES_CAMS |
26 |
0.095808 |
0.195608 |
0.805 |
KEGG_ALZHEIMERS_DISEASE |
24 |
0.087302 |
0.183226 |
0.805 |
KEGG_PATHWAYS_IN_CANCER |
48 |
0.098 |
0.185527 |
0.831 |
KEGG_AXON_GUIDANCE |
17 |
0.11553 |
0.176978 |
0.834 |
KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION |
24 |
0.136538 |
0.210733 |
0.893 |
KEGG_DILATED_CARDIOMYOPATHY |
15 |
0.165339 |
0.237117 |
0.925 |
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY |
19 |
0.168932 |
0.240447 |
0.932 |
KEGG_MELANOGENESIS |
15 |
0.252033 |
0.367091 |
0.99 |
KEGG_LYSOSOME |
18 |
0.329389 |
0.436596 |
0.996 |
KEGG_CALCIUM_SIGNALING_PATHWAY |
19 |
0.367886 |
0.427407 |
0.996 |
KEGG_WNT_SIGNALING_PATHWAY |
24 |
0.361616 |
0.414545 |
0.996 |
KEGG_ENDOCYTOSIS |
20 |
0.365503 |
0.423908 |
0.998 |
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION |
15 |
0.419958 |
0.454951 |
0.999 |
KEGG_HUNTINGTONS_DISEASE |
18 |
0.568465 |
0.60777 |
1 |
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON |
29 |
0.74269 |
0.769736 |
1 |
KEGG_PURINE_METABOLISM | 20 | 0.933054 | 0.931545 | 1 |
NOM P nominal P value.